---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-062559"
form_type: "8-K"
ticker: "TOVX"
cik: "0000894158"
company_name: "Theriva Biologics, Inc."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T21:47:27.091701+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Theriva Biologics sets 2025 annual meeting for August 29; proxy deadlines revised

## Summary
- Annual meeting scheduled for August 29, 2025; record date for voting is July 8, 2025.
- Stockholder proposals under Rule 14a-8 must be received by July 5, 2025 for inclusion in proxy materials.
- Director nominations or other proposals not seeking inclusion must be delivered by July 5, 2025.
- Universal proxy rule compliance notice for director nominees also due by July 5, 2025.

## SEC filing metadata
- accession: 0001104659-25-062559
- form_type: 8-K
- ticker: TOVX
- cik: 0000894158
- company_name: Theriva Biologics, Inc.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/894158/000110465925062559/0001104659-25-062559-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/894158/000110465925062559/tm2518991d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-062559
- JSON: https://secwatch.observer/filing/0001104659-25-062559.json
- Plain text: https://secwatch.observer/filing/0001104659-25-062559.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.